Abstract

Complex conformational dynamics are essential for function of the dimeric molecular chaperone heat shock protein 90 (Hsp90), including transient, ATP-biased N-domain dimerization that is necessary to attain ATPase competence. The intrinsic, but weak, ATP hydrolyzing activity of human Hsp90 is markedly enhanced by the co-chaperone Aha1. However, the cellular concentration of Aha1 is substoichiometric relative to Hsp90. Here we report that initial recruitment of this cochaperone to Hsp90 is markedly enhanced by phosphorylation of a highly conserved tyrosine (Y313 in Hsp90α) in the Hsp90 middle domain. Importantly, phosphomimetic mutation of Y313 promotes formation of a transient complex in which both N- and C-domains of Aha1 bind to distinct surfaces of the middle domains of opposing Hsp90 protomers prior to ATP-directed N-domain dimerization. Thus, Y313 represents a phosphorylation-sensitive conformational switch, engaged early after client loading, that affects both local and long-range conformational dynamics to facilitate initial recruitment of Aha1 to Hsp90.

Phosphorylation of Tyr313 in Hsp90 enhances the binding to its activator Aha1, but the underlying mechanism is unknown. Here, the authors study the structural consequences of Tyr313 phosphorylation, showing that it serves as a conformational switch in Hsp90 that enables Aha1 recruitment.

Details

Title
Hsp90 middle domain phosphorylation initiates a complex conformational program to recruit the ATPase-stimulating cochaperone Aha1
Author
Xu, Wanping 1 ; Beebe, Kristin 1 ; Chavez, Juan D 2 ; Boysen, Marta 3 ; Lu YinYing 4 ; Zuehlke, Abbey D 1 ; Keramisanou Dimitra 5 ; Trepel, Jane B 6 ; Prodromou Christosomos 7   VIAFID ORCID Logo  ; Mayer, Matthias P 3   VIAFID ORCID Logo  ; Bruce, James E 2 ; Gelis Ioannis 5 ; Neckers Len 1   VIAFID ORCID Logo 

 National Cancer Institute, Urologic Oncology Branch, Bethesda, USA (GRID:grid.48336.3a) (ISNI:0000 0004 1936 8075) 
 University of Washington School of Medicine, Department of Genome Sciences, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657) 
 University of Heidelberg, Center for Molecular Biology, Heidelberg, Germany (GRID:grid.7700.0) (ISNI:0000 0001 2190 4373) 
 National Cancer Institute, Urologic Oncology Branch, Bethesda, USA (GRID:grid.48336.3a) (ISNI:0000 0004 1936 8075); Beijing 302 Hospital, Center for Therapeutic Research of Hepatocarcinoma, Beijing, China (GRID:grid.413135.1) (ISNI:0000 0004 1764 3045) 
 University of South Florida, Department of Chemistry, Tampa, USA (GRID:grid.170693.a) (ISNI:0000 0001 2353 285X) 
 National Cancer Institute, Developmental Therapeutics Branch, Bethesda, USA (GRID:grid.48336.3a) (ISNI:0000 0004 1936 8075) 
 University of Sussex, Genome and Damage Stability Center, Brighton, UK (GRID:grid.12082.39) (ISNI:0000 0004 1936 7590) 
Publication year
2019
Publication date
2019
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2239168262
Copyright
© This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.